NCT03076164 A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib Status COMPLETED Phase PHASE1/PHASE2
NCT03068507 The Impact of Trimodal Prehabilitation Strategy on Patients Undergoing Thoracoscopic Lobectomy Status COMPLETED Phase NA
NCT03058289 A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 Status COMPLETED Phase PHASE1/PHASE2
NCT03051802 Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and Lung Status TERMINATED Phase NA
NCT03050047 A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT03048760 Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients Status COMPLETED Phase NA
NCT03047616 A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer Status COMPLETED Phase N/A
NCT03047525 Study of DC-CTL Combined With CIK for Advanced Solid Tumor Status UNKNOWN Phase PHASE1/PHASE2
NCT03041181 Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor Status TERMINATED Phase PHASE2
NCT03007953 Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II Status COMPLETED Phase NA
NCT03004586 Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle Status COMPLETED Phase NA
NCT02997501 T790M Plasma Testing Methodology Comparison and Clinical Validation Status COMPLETED Phase PHASE3
NCT02989974 Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program Status COMPLETED Phase NA
NCT02978586 A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors Status COMPLETED Phase N/A
NCT02964689 Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC. Status COMPLETED Phase PHASE1